Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;41(2):529-536.
doi: 10.1007/s00345-022-04260-4. Epub 2022 Dec 19.

Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database

Nicholas Corsi #  1 , David-Dan Nguyen #  2 , Adel Arezki  3 , Iman Sadri  3 , Kyle Law  4 , David Bouhadana  5 , Claudia Deyirmendjian  4 , Naeem Bhojani  4 , Dean S Elterman  2 , Franck Bruyère  6 , Luca Cindolo  7 , Giovanni Ferrari  7 , Carlos Vasquez-Lastra  8 , Tiago Borelli-Bovo  9 , Edgardo F Becher  10 , Hannes Cash  11 , Maximillian Reimann  12 , Enrique Rijo  13 , Vincent Misrai  14 , Bilal Chughtai  15 , Kevin C Zorn  16
Affiliations

Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database

Nicholas Corsi et al. World J Urol. 2023 Feb.

Abstract

Introduction: GreenLight photoselective vaporization of the prostate (PVP) has gained widespread adoption as an option to traditional transurethral resection of the prostate. Prior reports expressed concern with the use of PVP in large prostates. The aim of this study was to investigate the adjusted outcomes of GreenLight PVP in men with large (≥ 80 cc) vs. small prostates (< 80 cc).

Methods: Data were obtained from the Global Greenlight Group which pools data from 7 high volume centers. Men with established benign prostatic hyperplasia who underwent GreenLight PVP using the XPS-180 W system between 2011 and 2019 were eligible and assigned into two groups based on their prostate size (≥ 80 and < 80 cc). 11 functional and perioperative covariates were collected. Analyses were adjusted for patient age and presence of median lobe.

Results: 3426 men met the inclusion criteria. 34.6% (n = 1187) of patients had a large prostate size. Baseline age and prostate volume were significantly different between the groups. The magnitude of absolute improvement in unadjusted international prostate symptom score was significantly greater in the large (≥ 80 cc) prostate group at 12 months, with an absolute change of 19.17 points (95% CI 18.46-19.88; p < 0.01). There was also a significant drop in PVR at both 6- (p = 0.007) and 12 months (p = 0.005). There were no significant differences in transfusion (p = 0.42), hematuria (p = 0.80), or 30-day readmission rates (p = 0.28).

Conclusions: Greenlight PVP is a safe and effective alternative for patients with prostate sizes ≥ 80 cc, with durable outcomes relatively independent from prostate size.

Keywords: BPH; GreenLight; IPSS; Large prostate; Photoselective vaporization of the prostate.

PubMed Disclaimer

References

    1. Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—the GOLIATH study. Eur Urol 65(5):931–942. https://doi.org/10.1016/j.eururo.2013.10.040 - DOI - PubMed
    1. Hueber PA, Bienz MN, Valdivieso R et al (2015) Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 194(2):462–469. https://doi.org/10.1016/j.juro.2015.03.113 - DOI - PubMed
    1. Lerner LB, McVary KT, Barry MJ et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II—surgical evaluation and treatment. J Urol 206(4):818–826 - DOI - PubMed
    1. Elshal AM, Soltan M, El-Tabey NA, Laymon M, Nabeeh A (2020) Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU Int 126(6):731–738. https://doi.org/10.1111/bju.15161 - DOI - PubMed
    1. McConnell JD, Roehrborn CG, Bautista OM et al (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. 25. http://www.nejm.org

LinkOut - more resources